Page last updated: 2024-08-26

arsenic and 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone

arsenic has been researched along with 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, LW; Hsieh, DP; Lee, HL; Lin, P; Tsai, MH; Ueng, YF; Wu, JP1
Chung, CJ; Hsueh, YM; Huang, CY; Lee, HL; Lin, P; Pu, YS; Su, CT; Wu, CC1

Other Studies

2 other study(ies) available for arsenic and 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone

ArticleYear
Enhancements of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism and carcinogenic risk via NNK/arsenic interaction.
    Toxicology and applied pharmacology, 2008, Feb-15, Volume: 227, Issue:1

    Topics: Animals; Arsenic; Body Weight; Carcinogens; Cytochrome P-450 Enzyme System; DNA Adducts; Growth; Hydroxylation; Male; Mice; Mice, Inbred ICR; Nitrosamines; Risk Factors; RNA, Messenger

2008
Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma.
    The Journal of urology, 2012, Volume: 188, Issue:5

    Topics: Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; Humans; Methylation; Nitrosamines; Pyridines; Risk; Smoking; Urologic Neoplasms

2012